tirzepatide weight regain study In participants with obesity/overweight, withdrawing led to substantial of lost weight, whereas continued treatment maintained and augmented initial reduction. https://t.co/lHnNOvL2X3 Tirzepatide did not impact metabolic

doi: 10.1007/s13679-023-00502-7 75 RobertsCAChristiansenPHalfordJCG

The results have been striking

Bioavailability and bioactivity of intravenous vs

Eli Lilly's prescribing information for Mounjaro (the branded tirzepatide product) states the same

GLP-1 GLP-11 GLP-1 GLP-1 GLP-111 2 GLP-1 GLP-1 GIPGLP-1-12GLP-1 GLP-1LGLP-1GLP-1 GLP-1 GLP-1 Point.1 GLP-1 GLP-1 Point.2 GLP-1 Point.3 GLP-1GLP- GLP-1 GLP-1GLP-111 InBodyBFI Measure InBody BFI Measure5BMIBMI GLP-1 GLP-1 GLP-1 GLP-1 STEP 1 STEP 2 GLP-1(2425) TP STEP 3 GLP-1

Most patients start with weekly injections for a set period, then reassess with their provider